15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 14 firms covering DR Horton Inc, 4 rate it Buy or better, 9 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $125.00 to $206.00, a moderate spread. The average target of $167.45 sits 11% above the current $150.99. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 4 over recent months. On the fundamentals, the Street sees consensus EPS building from about $2.24 next quarter toward $11.69 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 ratings
Moderate Buy
Strong Buy00%
Buy429%
Hold964%
Sell17%
Strong Sell00%
Based on 14 analysts giving stock ratings to DR Horton Inc.
As of Jul, 4 of 14 firms rate DHI a Buy (9 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
DHI EPS & revenue forecast
EPS · NEXT QUARTER
$2.24
Range $1.84 – $2.40 · 10 analysts · +11% YoY
Next period, 10 analysts expect DR Horton Inc to earn $2.24 a share (range $1.84 – $2.40), versus $2.03 a year earlier. Full-year consensus is $10.44, growing to $11.69 the year after.
REVENUE · NEXT QUARTER
$7.4B
Range $6.9B – $8.1B · 10 analysts · +7% YoY
Revenue is expected to reach $7.4B (range $6.9B – $8.1B), +7.2% year-over-year. Full-year consensus is $32.8B, rising to $34.6B next year.
Top analysts covering DR Horton Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on DHI.
#1
Jade Rahmani
Keefe, Bruyette & Woods · Rank #8
Hold
$167.00+10.6% to target
Overall win rate
59%
+ Follow
#2
AP
Anthony Pettinari
Citigroup · Rank #84
Hold
$173.00+14.6% to target
Overall win rate
45%
+ Follow
#3
Mike Dahl
RBC Capital · Rank #173
Sell
$125.00-17.2% to target
Overall win rate
45%
+ Follow
#4
Buck Horne
Raymond James · Rank #270
Hold
No targeton DHI
Overall win rate
37%
+ Follow
#5
Tyler Batory
Oppenheimer · Rank #308
Hold
No targeton DHI
Overall win rate
25%
+ Follow
DHI stock forecast FAQ
What is DHI's average 12-month price target?+
The 11 analysts with a live target average $167.45 for DR Horton Inc over the next 12 months, ranging from a $206.00 high to a $125.00 low.
Is DHI stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 14 analyst ratings, 4 are Buy or Strong Buy, 9 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for DHI?+
The Street-high target is $206.00 (UBS), and the Street-low is $125.00 (RBC Capital). The average of all 11 active targets is $167.45.
How many Wall Street analysts cover DHI?+
14 analysts have an active rating on DR Horton Inc, and 11 firms carry a live 12-month price target.
Who is the most accurate analyst covering DHI?+
Among analysts who currently cover DHI, Jade Rahmani of Keefe, Bruyette & Woods has the strongest overall Quantellect track record (Rank #8). Their current call is Hold with a $167.00 target.
What is DR Horton Inc's projected EPS for next quarter?+
The consensus estimate is $2.24 per share (range $1.84 – $2.40) across 10 analysts. Full-year EPS is projected at $10.44, rising to $11.69 the following year.
How much revenue is DR Horton Inc expected to report next quarter?+
Consensus revenue is $7.4B (range $6.9B – $8.1B). Full-year revenue is projected at $32.8B, growing to $34.6B next year.
Have analysts been upgrading or downgrading DHI lately?+
As of Jul, 4 of 14 firms rate DHI a Buy (9 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their DHI calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
